Two Seed IP partners are scheduled to attend the upcoming networking event, "Beyond CAR-T – Next-Gen Cell and Immunotherapies," event taking place at Bristol Myers Squibb, 400 Dexter Ave N, Seattle, WA, on October 29 from 5:30-8:00 p.m. Presented by Women in Bio Seattle, the event will explore cutting-edge advancements in engineered T-cell therapies and immune cell therapy innovation. Attendees will learn about the successes and challenges driving the industry forward, and gain valuable insights into what's next for this transformative science.

Attending from Seed IP:

Michelle M. LeCointe | Partner, Seed IP Law Group LLP

John A. Morgan | Partner, Seed IP Law Group LLP

Learn more about Executive Women in Bio Seattle.

‍